View Cart (0 items)

Items Tagged with 'novartis'


Novartis to sell influenza vaccines business for $275 million

Healthcare company Novartis has entered into an agreement to sell its influenza vaccines unit for $275 million.
Read More

New heart failure drug could cut deaths by 20%

Swiss pharmaceuticals group Novartis is planning to launch a new drug that has the potential to cut cardiovascular death and admissions to hospital by 20%.
Read More

Asia offers big business opportunities to pharma companies

Asia is emerging as a strategically important location for global pharmaceutical companies that are looking to take advantage of the opportunities available in terms of R&D, manufacturing and market.
Read More